SUBSCRIBE
SUBSCRIBE
News   FDA

OBS Medical Announces FDA Clearance of New Patient Safety Technology

October 1, 2007 | 
1 min read

INDIANAPOLIS--(BUSINESS WIRE)--OBS Medical announced today that the Food and Drug Administration has granted 510(k) clearance for the company to market its next generation patient deterioration early warning system (VisensiaTM) in the United States.

FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Approvals
Ionis’ Tryngolza Becomes First FDA-Approved Therapy for Familial Chylomicronemia Syndrome
December 20, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Confirms Lilly’s GLP-1s Are Not in Shortage, Gives Compounders Grace Period
December 19, 2024
 · 
3 min read
 · 
Tristan Manalac
Pictured: 3D illustration of stem cells used for cell therapy
Cell therapy
Mesoblast Wins First Mesenchymal Stromal Cell Therapy FDA Approval for GVHD
December 19, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman makes employee cuts as part of layoff
Layoffs
The 5 Largest Biopharma Layoffs of 2024
December 19, 2024
 · 
7 min read
 · 
Angela Gabriel